Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Tiopronin Delayed-Release Tablets delayed-release tablets, for oral use These highlights do not include all the information needed to use Tiopronin Delayed-Release Tablets safely and effectively. See full prescribing information for Tiopronin Delayed-Release Tablets. Initial U.S. Approval: 1988
Medication labelWhy this: Advisory · dailymed-prescription
Tiopronin Delayed-Release Tablets are indicated, in combination with high fluid intake, alkali, and diet modification, for the prevention of cystine stone formation in adults and pediatric patients 20 kg and greater with severe homozygous cystinuria, who are not responsive to these measures alone.
- generic_name
- tiopronin
- product_names
- Tiopronin
- ndc
- 44523-054, 44523-055, 44523-054-01, 44523-055-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en